Per Ingemar Lindell

Per Ingemar Lindell, Sc.D., M.Sc. is a biopharmaceutical and life sciences expert specializing in drug discovery, clinical development, and biologics manufacturing litigation. With a career spanning management consulting, strategic planning, and operational management, he brings a comprehensive framework to litigation work involving complex biopharmaceutical processes. His work centers on investigating gene therapy development, assessing peptide drug manufacturing, and evaluating whether trade secrets were misappropriated.

Mr. Lindell has been retained in numerous expert witness and consulting engagements across the United States and Europe, involving gene therapy, peptide drugs, and cell bank storage disputes. His Doctor of Science in Biochemical Engineering from MIT, along with his Master of Science in Chemical Engineering from the Royal Institute of Technology, Sweden, reinforce his ability to deliver objective, defensible analyses. He is regularly engaged by both plaintiff and defense counsel to provide clear, independent determinations of causation in disputes involving biopharmaceutical development and manufacturing processes.